Where’s the Market Now?

There are lots of things, apparently, I do not understand about the economics of pharmaceuticals.

Here is a story from The New York Times about the American dwindling supplies of an anti-cancer drug for kids (We may run out completely in a matter of weeks, according to the article.).

A crucial medicine to treat childhood leukemia is in such short supply that hospitals across the country may exhaust their stores within the next two weeks, leaving hundreds and perhaps thousands of children at risk of dying from a largely curable disease, federal officials and cancer doctors say.

The drugs are wildly popular because, well, they seem to work. Their price has increased in some quarters “eightyfold.” Shouldn’t market forces dictate that such a drug would be amply produced and available to help children fight cancer?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s